Baring India backs drug developer
The Delhi-based private equity firm will invest up to $15m in Sphaera Pharma. It is the first deal for its $550m Fund III closed earlier this year.
5 January 2013•1 min read
The Delhi-based private equity firm will invest up to $15m in Sphaera Pharma. It is the first deal for its $550m Fund III closed earlier this year.
